Diet Pill News
ORLANDO, Fla. – A second study confirms that an experimental diet pill can help people lose weight and keep it off for up to two years, setting the stage for its maker to seek approval to sell it in the United States.
The drug, rimonabant, which the French company Sanofi-Aventis hopes to sell under the brand name Acomplia, trimmed nearly 16 pounds on average from people taking the optimal dose for two years, compared with 5.5 pounds for those who took dummy pills, doctors reported Tuesday at a cardiology conference.
“The majority of the weight that was lost at one year is still maintained after two years. There is only a slight increase over that second year,” said Dr. Luc Van Gaal of University Hospital in Antwerp, Belgium, who led the company-funded study involving 1,507 severely obese people in Europe. Order Diet Pills
The government on Wednesday approved over-the-counter sales of the fat-blocking diet pill orlistat, allowing direct sales for the first time of a version of a diet drug that had been available only by prescription.
Currently available as Xenical, the capsules will be sold in a lower, nonprescription dose under the name “alli.”
The drug is intended for people 18 and older to use along with a reduced-calorie, low-fat diet and exercise.
When taken with meals, orlistat blocks the absorption of about one-quarter of any fat consumed. That fat about 150 to 200 calories worth is passed out of the body in stools, which can be loose as a result. About half of patients in trials experienced gastrointestinal side effects. adipex
The new drug would contain half the dose of Xenical prescription capsules and would cost consumers $12 to $25 a week, GlaxoSmithKline has said. The company estimated 5 million to 6 million Americans a year would buy the drug over the counter. Those numbers could mean at least $1.5 billion a year in retail sales.
The Food and Drug Administration said the most common side effect of the product is a change in bowel habits. Eating a low fat diet will reduce the likelihood of this side effect.
Also, FDA said people who have had organ transplants should not take OTC orlistat because of possible drug interactions. In addition, anyone taking blood thinning medicines or being treated for diabetes or thyroid disease should consult a physician before using orlistat, the agency said.
GSK Consumer Healthcare, which will market the pill, said it chose the name alli to indicate a partnership with consumers in their weight-loss efforts.
“We know that being overweight has many adverse consequences, including an increase in the risk of heart disease and type 2 diabetes,” said Dr. Douglas Throckmorton, deputy director for the FDA’s Center for Drug Evaluation and Research. buy phentermine